Scintilate's Musings

Although the cannabinoids THC and CBD are the only two cannabinoids required to be disclosed by the Licensed Producers under Canada's marijuana legislation, some dispensaries in the US also only disclose these two cannabinoids in their strains, choosing to ignore the following cannabinoids that have a greater presence over CBD in Indica strains:  Cannabigerol (CBG)  - the link for this cannabinoid is for a patent application filed by GW Pharmaceuticals in treating depression and other mood disorders.  CBG for a number of diseases  - the diseases or conditions to be treated are taken from the group: pain, neurodegenerative disease, ischemic disease, brain injury or damage, acquired brain injury, age related inflammatory or autoimmune disease, cachexia, nausea and vomiting, glaucoma, movement disorders, rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, diabetes, cancer, osteoporosis, renal ischemia and nephritis...

After the Harper government implemented the new Marijuana for Medical Purposes Regulations (MMPR), it became a crime in Canada to grow cannabis for personal medicinal use, as allowed under the previous regulations.  In a short period of time, after the MMPR came into existence, court cases were heard. The most significant Supreme Court Cases since the inception of the new MMPR were Smith v. Canada and Allard et al v. Canad a. In both decisions, the Supreme Court found that the MMPR violates our Charter of Rights. The emerging cannabis industry in Canada was sold to "big corporations", by Health Canada, as an emerging multi-billion dollar industry . It seems Health Canada assumed we, as patients, are all ignorant, docile and would just do as we are told regardless of incomprehensible legislation.  Health Canada states that they protect Canadians health (assuming, of course, we are individually unable to make intelligent personal health care decisions ourselves) at ...

ECO 101 - Any introductory course to economics describes the theory of supply and demand; the market system; the concept of inflation, deflation, stagnation; monetary policy and central banks; and more.  FIN 301 - Finance, at the intermediate to advance level in the pursuit of any business degree, will have you learn the concept of the time value of money (TVM). The principle behind the " time value of money " is simply "a dollar today is worth more than a dollar tomorrow".  However, the definition of the TVM becomes convoluted as follows: Investopedia defines the TVM as   the idea that money available at the present time is worth more than the same amount in the future due to its potential earning capacity. This core principle of finance holds that, provided money can earn interest, any amount of money is worth more the sooner it is received. Try reconciling the basic principles of economics in which a fair and equal market determines a...

According to the National Institute of Health (NIH), "medicines today are expected to be of known composition and quality. Even in cases where marijuana can provide relief of symptoms, the crude plant mixture does not meet this modern expectation. The future of medical marijuana lies in classical pharmacological drug development, and indeed there has been a resurgence of scientific, as well as public, interest in the therapeutic applications of cannabinoids."   Further -  "Current scientific accomplishments have propelled interest in developing new drugs that can treat more effectively or more safely the constellation of symptoms for which cannabinoids might have therapeutic benefit  Through the process of what is referred to as “rational drug design,” scientists manipulate the chemical structures of known cannabinoids to design better therapeutic agents." Under the Controlled Substances Act, cannabis is a schedule 1 drug and participating co...

The practice of family medicine in Canada was in considerable decline in the years leading up to the founding of The College of Family Physicians of Canada in 1954.  The College of Family Physicians of Canada (CFPC) published preliminary guidelines for the Physicians in Canada. The regulatory board governing doctors in Canada states that the new Marijuana for Medical Purposes Regulations (MMPR) has put doctors in a "difficult position: we are asked to authorize our patients’ access to a product with little evidence to support its use, and in the absence of regulatory oversight and approval." According to this regulatory body, physicians in Canada must be on the alert for 'cannabis use disorder' in those patients seeking medical marijuana. This regulatory board further contends that by grouping cannabis in with cocaine, alcohol and other drugs, a number of harmful effects exist in cannabis, alcohol, cocaine, amphetamines, etc.  The CFPC advises...